SN
Sean P. Nolan (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Taysha Gene Therapies, Inc. (TSHA). The largest single filing was $840K of TSHA (178,101 sh across 2 lots, as filed), executed Jan 23. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$840K
shares × price, as filed
Last traded
Jan 26
Filed Jan 27
Median ADV $19.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $840K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
TSHARecent filings
TSHASALE
Taysha Gene Therapies, Inc.
View filing →
$840K178,101 sh across 2 lots
Exec Jan 23
Filed Jan 27 · 5:30 PM ET